Pharma IQ Members

Clinical Supply
33 results
of 3
Contributor: Pharma IQ
Posted: Tue, 12/12/2017
Data in medicine
The recent Data Analytics in Pharma Development conference inspired many with the truth of how data can power the future of medicine. Full Content »
Contributor: Chanice Henry
Posted: Tue, 11/14/2017
AI in Pharma
Drug development approaches a fascinating era as the trend of digitalization introduces sophisticated technologies which can neutralize the costly hazards faced in pharma’s R&D pipelines, according to a new deep-dive study by Pharma IQ Full Content »
Contributor: Pharma IQ News
Posted: Tue, 10/31/2017
pharma-ai-video-report
Pharma IQ looks at the potential of artificial intelligence in drug discovery. Full Content »
Contributor: Pharma IQ
Posted: Fri, 07/14/2017
AI thumb
Artificial intelligence could herald a new era for drug development but caution remains about how revolutionary its impact will actually be Full Content »
Contributor: Pharma IQ
Posted: Fri, 07/14/2017
Trial Master File Europe 2017
If your company was handed with a notice for a clinical trial inspection right now, what would the reaction be? A feeling of calm confidence or a rush of slight concern? In this ebook Pharma IQ compared the perspectives of a Clinical Research Organisation (CRO) to that of a sponsor concerning the burning topic of trial master file inspection readiness. Full Content »
Contributor: Editorial Staff
Posted: Wed, 03/08/2017
Creativity Versus Innovation
It's true: Many confuse the process of getting ideas with the agonizing realities of putting them to work.Lack of creativity is not the problem in most organizations. Great ideas almost always abound.The real problem is converting an idea, which is just a good intention, into operational reality.Indeed, a powerful new idea can kick around unused... Full Content »
Contributor: Social Monsters.org
Posted: Tue, 02/14/2017
cloud, pharma, analytics, data, healthcare data, healthcare analytics, healthcare, big data, big data pharma, pharma big data,
After years of resistance, the health care and pharmaceutical industries are now accelerating full steam towards the cloud. In fact, the global health care cloud computing market, valued at $4.5 billion in 2016, will reach $9.5 billion by 2020. Here are the dominant benefits that are drawing these giants to the cloud. Full Content »
Contributor: George Clinical Representative
Posted: Tue, 01/24/2017
Georger
The field of clinical research is growing and advancing thanks to technological advances like real time data collection and analysis, health care applications, and wearable technologies. The clinical trial industry is seeing huge strides thanks to these digital and technological advances that are making studies more efficient, faster, safer, and garnering more participants Full Content »
Contributor: Pharma IQ
Posted: Tue, 01/17/2017
Pharma IQ
The melanoma pipeline, which is typically underserved due to stubborn R&D challenges, is being praised for its levels of innovation as of late with 579 programs active across all stages of development, with 226 first-in-class programs in the pipeline, acting on 138 distinct first-in-class molecular targets. This accounts for 38% of all programs with a disclosed molecular target and reflects the high degree of innovation in this indication, according to business intelligence provider GBI Research. Full Content »
Contributor: Pharma IQ
Posted: Tue, 12/20/2016
Pharma IQ
The last quarter of 2016 was certainly not short of activity with a £84 million pharma fine issued in regards to drug pricings, an investigation into a suspected supply chain breach and numerous therapeutic approvals. Full Content »
33 results
of 3
Contributor: Pharma IQ
Posted: Tue, 12/12/2017
Pharma IQ
The recent Data Analytics in Pharma Development conference inspired many with the truth of how data can power the future of medicine.In this short video, Nigel Hughes, Scientific Director, RMEDS Quantitative Sciences at Janssen R&D provides a few key lessons on the matter. Full Video »
Contributor: Chanice Henry
Posted: Tue, 11/14/2017
Chanice Henry
Drug development approaches a fascinating era as the trend of digitalization introduces sophisticated technologies which can neutralize the costly hazards faced in pharma’s R&D pipelines, according to a new deep-dive study by Pharma IQ Full Sector Report »